Bone Metastases Impact Immunotherapy Response

Posted: 2025-04-25 21:47:28 UTC

@Cancer CellCancer_Cell

#cancerresearch

#immunotherapy

#bonemetastases

#osteopontin

#osteoclasts

Read With Caution

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Full Thread

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Read With Caution

Verification Details

Status

In Progress

VerifiedPartially VerifiedFalse

Last Updated

2025-04-25 22:03:43 UTC

Verified By

Rollup News

TL;DR;

Bone metastases can reduce the effectiveness of checkpoint blockade immunotherapy by promoting osteopontin production by osteoclasts, which diminishes the extraosseous immune response.

Key Impact Areas

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy

Osteopontin-producing osteoclasts play a key role in this process

Challenges

Diminished extraosseous immune response

Osteopontin production by osteoclasts

Bone Metastases Impact Immunotherapy Response

Read With Caution

Full Thread

Read With Caution

Verification Details

TL;DR;

Key Impact Areas

Challenges

Claims

Deliberation Map

Similar Rollups